FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of skin scars. Disclosed is the use of a composition comprising an effective amount of a peripheral blood mononuclear cell (PBMC) cell culture supernatant for treating a skin scar, wherein said skin scar is a hypertrophic scar or a keloid scar, wherein the PBMC cell culture contains from 1*105 to 1*108 PBMCs/ml, and the PBMCs are exposed to ionizing radiation in a dose of at least 10 Gy before or during cultivation, wherein said PBMC cell culture contains monocytes, T-cells, B-cells and NK-cells. Also disclosed is a method for cosmetic treatment of skin scars.
EFFECT: group of inventions provides removal/treatment of skin scars, which does not require surgical intervention.
10 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING HYPERTROPHIC CICATRIX DEVELOPMENT AFTER MAMMOPLASTY OPERATION | 2006 |
|
RU2320995C1 |
| METHOD FOR ELIMINATION OF CICATRICAL SKIN CHANGES | 2020 |
|
RU2731527C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING WOUND OR SCAR CONTAINING BENZBROMARONE | 2021 |
|
RU2816016C1 |
| METHOD OF TREATING PATHOLOGICAL CICATRICAL SKIN DEFORMITIES | 2015 |
|
RU2599868C1 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
| COMPOSITION AND METHOD OF TREATING SKIN SCARS | 2013 |
|
RU2705211C2 |
| HUMANISED ANTI-TGF-BETA-ANTIBODY | 2005 |
|
RU2386638C2 |
| METHOD OF HYPERTROPHIC OR KELOID SKIN CICATRIXES TREATMENT | 2006 |
|
RU2335307C1 |
| GEL FOR TREATMENT, PREVENTION OF FORMATION OF KELOID AND HYPERTROPHIC SKIN CICATRICES AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2377975C2 |
| CELL AND CELL EXTRACT INTRODUCTION FOR REJUVENATION | 2007 |
|
RU2421208C2 |
